intratio Posted - 20 hours ago

https://www.intratio.com/stock-forecast/ALRN Our model assessed that this equity s value has a very negative short-term outlook with a very negative long-term outlook $ALRN

Stock_Titan Posted - 1 day ago

$ALRN Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights https://www.stocktitan.net/news/ALRN/aileron-therapeutics-reports-first-quarter-2024-financial-results-81b4ex1i5qlv.html

intratio Posted - 2 days ago

$ALRN https://www.intratio.com/stock-forecast/ALRN The automated equity analyst has detected that this stock s price will fall in the upcoming week and will have a very negative trend in the upcoming months

Dollar_D Posted - 1 week ago

$ALRN well, what happened?

Stocksrunner Posted - 1 week ago

📉💼 Turnaround Alert: $NET $NCLH $ENOV $ALRN show signs of potential reversal after entering oversold territory! Keep an eye on these for a possible comeback! 🔄📈

intratio Posted - 1 week ago

$ALRN https://www.intratio.com/stock-forecast/ALRN The automated equity analyst foresees that the market value of this company has bleak prospects for the foreseeable future and has a dramatic negative long-term outlook

Dollar_D Posted - 1 week ago

$ALRN

NetworkNewsWire Posted - 1 week ago

BioMedNewsBreaks — $ALRN Closes Underwritten Registered Direct Offering https://ibn.fm/XB8z7

intratio Posted - 1 week ago

https://www.intratio.com/stock-forecast/ALRN Aileron Therapeutics, Inc. Our predictive algorithm is making the inference this company s market value has a poor outlook for the near future and has really poor long-term fundamentals $ALRN

Dollar_D Posted - 1 week ago

$ALRN offering is closed. Time to fly now

hatsam Posted - 1 week ago

$PBM we hit that $1.6!! We might move to second level. Just like $ALRN this will fly higher.

insiderbuyingselling Posted - 2 weeks ago

$ALRN new insider selling: 31151 shares. http://insiderbuyingselling.com/?t=ALRN

ProfitGainer Posted - 2 weeks ago

$ALRN I had hoped for a run before an offering, but I think the worst is over now. Also got positive trial data today, which is a plus.

daprinta Posted - 2 weeks ago

$ALRN Buying w/2hands…Q3 data will be compelling & this story will end in M&A Heaven…north of $25🙌

CycleTrade Posted - 2 weeks ago

$ALRN needs a bounce

DonCorleone77 Posted - 2 weeks ago

@MaverikIT @net0trader @Wigglyick @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski @IsabellaDC @CycleTrade $ALRN Keeping an eye on this one today. Interested in seeing if the data (below) and offering have any significant effect:

DonCorleone77 Posted - 2 weeks ago

$ALRN Aileron Therapeutics announces data from Cohort 1 of Phase 1b trial of LTI-03 Aileron Therapeutics announced positive data from Cohort 1 of the ongoing Phase 1b clinical trial evaluating the safety and tolerability of inhaled LTI-03 in patients diagnosed with idiopathic pulmonary fibrosis. Following inhaled administration of low dose LTI-03, a positive trend was observed in seven out of eight biomarkers with evidence of reduced expression among profibrotic proteins produced by basal-like cells and fibroblasts that contribute to the progression of IPF, including data from several biomarkers that were statistically significant, reinforcing the potential of LTI-03 to improve lung function and reverse the course of IPF. "We find it encouraging that low dose LTI-03 achieved statistical significance in three out of eight biomarkers evaluated in the trial" said Brian Windsor, Ph.D., President and Chief Executive Officer of Aileron. "This, paired with the positive trends observed in several of the other biomarkers, strengthens our belief that LTI-03 has the potential for disease stabilization or even reversal. We look forward to continuing to evaluate LTI-03 in the ongoing Phase 1b study and sharing results from the high-dose cohort later this year."

DonCorleone77 Posted - 2 weeks ago

$ALRN Aileron Therapeutics prices 4.27M shares at $4.68 in registered direct offering Aileron Therapeutics announced the pricing of an underwritten registered direct offering priced at-the-market under Nasdaq rules of 4,273,505 shares of its common stock and accompanying warrants to purchase an aggregate of 4,273,505 shares of common stock. Each share of common stock and accompanying warrant are being sold together at a combined public offering price of $4.68. The aggregate gross proceeds of the offering are expected to be approximately $20 million, before deducting underwriting discounts and commissions and other offering expenses payable by Aileron, and excluding any proceeds that may be received from exercise of the warrants. The offering is expected to close on or about May 3, 2024, subject to the satisfaction of customary closing conditions. The accompanying warrants will have an exercise price of $4.68 per share, will be exercisable immediately and will expire three years from the date of issuance. Aileron may call the warrants for cancellation during the ten trading day period after the date that is thirty days following the public announcement by Aileron of the top-line results from the Phase 1b clinical trial of LTI-03 in patients with idiopathic pulmonary fibrosis, which announcement includes a statement that there were no drug-related adverse events that resulted in a discontinuation of the trial; provided that Aileron may only deliver such call notice if the volume-weighted average price of its shares of common stock exceeds the exercise price of the warrants on the trading day immediately prior to the date it delivers the call notice. Any warrant subject to such call for which a notice of exercise is not received will be cancelled ten trading days after the date of the call notice for consideration equal to $0.001 per warrant share. Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering.

arrotrader Posted - 2 weeks ago

$ALRN Man, brutal. Results and offering not even 15 minutes later. Glad I got distracted with PALI or else I probably would have taken a bite here.

Stock_Titan Posted - 2 weeks ago

$ALRN Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million https://www.stocktitan.net/news/ALRN/aileron-therapeutics-announces-pricing-of-underwritten-registered-vhfxnimx8e2e.html

YoloAlfred Posted - 2 weeks ago

$ALRN added 400 shares at the ask

Stock_Titan Posted - 2 weeks ago

$ALRN Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) https://www.stocktitan.net/news/ALRN/aileron-therapeutics-announces-positive-data-from-cohort-1-of-the-qvu6lov97q8f.html

ProfitGainer Posted - 04/25/24

$ALRN Recent PT of $19. I expect it will run hard eventually before a PO.

VrtcIl Posted - 04/22/24

$ALRN is currently achieving new intraday highs, showing a bullish momentum on the technical charts. How far can this thing run guys? Price: 5.35 Float: 3.5M Short Float: 0.9 % 💰 Dollar Volume: 139.7K ℹ️ USA | Biotechnology

Moneyball1 Posted - 04/18/24

$ALRN I’m sure the Dow/market giving up 300pts may have impacted performance. Patience here, $19 is a no brainer if you have the patience. Not this week or next but in the next couple of years for sure. 3x return from here easy.

PumpmeDumpme Posted - 04/18/24

$ALRN where is this going guys? back to 4 bucks?

_www_larval_com_ Posted - 04/18/24

$ALRN just turned -6% lower to 20% (~2Mv) a few minutes ago, follow for more volatility.

PumpmeDumpme Posted - 04/18/24

$ALRN Maybe a new downgrade or patent really sucks?

shelby1 Posted - 04/18/24

$ALRN WTF was that

juanek Posted - 04/18/24

$SINT $ALRN a great day!